• Facebook
  • X
  • Events
  • News
  • Donate
Search
Hit enter to search or ESC to close
New Jersey Alliance for Clinical and Translational Science New Jersey Alliance for Clinical and Translational Science
  • Home
  • About
    • Mission
    • Membership
    • Affiliated Institutions
    • NJ ACTS Leadership
    • Cite the CTSA and Publications
    • CTSA Resources
    • Elements
  • Community
    • Our Services
    • Community Leadership
    • Volunteering for a Clinical Trial FAQs
    • Find a Clinical Trial
    • Partnership & Innovation Funding Opportunities
    • COVID-19 Resources
  • Investigator Resources
    • Funding Opportunities
    • Biostatistics, Epidemiology, Research Design (BERD)
    • Informatics Services
    • Regulatory Knowledge & Support
    • Special Populations in Research
    • Team Science
    • Genetically informed Research, Education, And Treatment
    • Biomarkers
    • ResearchMatch (RM)
    • Dissemination & Implementation Workgroup
    • COVID-19
    • Additional Resources
  • Education & Training
    • Workforce Development
    • R25 Clinical Research Experiential Summer Training (CREST)
    • Badges
    • Seminars, Workshops, Media Library
    • Learning Health System – STAR
    • Promoting STEM in High School and Earlier
    • Undergraduate Education and Training
    • Beyond Traditional Graduate Courses
    • NJ ACTS Collaborative Graduate Programs
  • K12 & T32
    • K12 Mentored Career Development Awards
    • T32 Predoctoral Training Awards
  • Clinical Trials Office
    • About
    • OnCore
    • Solutions
    • Services
    • I want to start a clinical trial
    • Resources
  • Contact Us
    • NJ ACTS Newsletter
Select Page

As Pfizer prepares to seek authorization for vaccine, FDA vows transparency

by William Jester | Nov 19, 2020 | Community, Covid, News

With coronavirus cases surging in the United States, the need for a vaccine is growing increasingly urgent, but federal officials have sought in recent days to reassure the public that the approval process for any potential vaccine will be thorough and...

Assessing COVID-19’s toll on Black physicians’ practices

by William Jester | Nov 19, 2020 | Community, Covid, News

As Dr. Pamela Huffman-DeVaughn watched some of her colleagues close the doors of their private practices, she feared she might have to do the same. Like many small-business owners, the physician felt the effects of the coronavirus. During the height of the pandemic,...

New Jersey Innovation Institute’s BioCentriq Aims to Usher in a New Era in Cell and Gene Therapies

by William Jester | Nov 18, 2020 | Community, News

To overcome production hurdles for cell and gene therapies, a promising new class of biologic medications, NJIT’s New Jersey Innovation Institute (NJII) has opened clinical-scale centers that will work directly with drug developers to streamline the processing of new...
Listen to Dr. Panettieri interview on the Pfizer vaccine

Listen to Dr. Panettieri interview on the Pfizer vaccine

by William Jester | Nov 18, 2020 | Community, Covid, News

Listen to Dr. Panettieri, the Vice Chancellor for Translational Medicine and Science at Rutgers University interview on 1010 WINS. As he reacts to Pfizer’s vaccine 95% effectiveness in preventing infections.

Coronavirus Test Results Are Faster but Still Too Slow for Contact Tracing, National Survey Says

by William Jester | Nov 18, 2020 | Community, Covid, News

The average test times for coronavirus results have fallen from four days in April to 2.7 days in September, but results are still too slow for effective contact tracing, according to a new nationwide survey led by researchers from Rutgers University–New Brunswick and...
« Older Entries
Next Entries »

Recent Posts

  • Join NJ ACTS on 10/26 for a Special Seminar
  • Join NJ ACTS Special Populations for a Seminar on 10/27
  • Join NCATS on 10/9 for the Director’s Roundtable
  • Mentoring Biomedical Graduate Students and Postdocs – Workshop 10/9
  • NJ ACS Community Event on 10/13 from 10:30 – 12:00

Archives

  • 2026
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2025
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2024
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2023
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2022
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2021
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2020
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2019
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2018
    • December

Categories

  • Community (2,503)
  • Covid (1,001)
  • CTO Events (7)
  • News (3,180)
  • Pilots (21)
Rutgers R Block logo graphic

THIS SITE

About

Membership

Community

Investigator Resources

Education & Training

News

Events

Contact

CONTACT US

New Jersey Alliance For Clinical and Translational Science (NJ ACTS)

 


  • Facebook

  • Twitter

  • YouTube

  • LinkedIn

© 2019, New Jersey Alliance for Clinical and Translational Science (NJ ACTS). All rights reserved.| Privacy Policy

Rutgers, The State University of New Jersey, is an equal access/equal opportunity institution. Individuals with disabilities are encouraged to direct suggestions, comments, or complaints concerning any accessibility issues with Rutgers web sites to accessibility@rutgers.edu or complete the Report Accessibility Barrier or Provide Feedback Form.